Glabellar Region

In short: The glabellar region is the topographic zone between the eyebrows and includes the procerus and corrugator supercilii muscles. One of the most expressive areas of the face, the primary center of aging with its glabellar "11 lines". Botox is the gold standard of treatment, but supratrochlear-ophthalmic vascular anastomosis carries the risk of blindness.

Description and Topography

The glabellar region (glabella — Latin "glaber" = smooth) is the flat frontal forehead located between the eyebrows. Anatomical boundaries: superior — hairline midline, inferior — nasion (root of the nose), lateral — orbital rim (eyebrow level medial). The zone includes the procerus muscle (medial, vertical) and the corrugator supercilii pair (bilateral, oblique). The average length of the region is 3-4 cm and its width is 2-3 cm; It is one of the most active areas of the face in facial expressions. People create expression by contracting this area in situations of concentration, anger, anxiety — over time, repetitive muscle activity turns into static lines.

Layers and the Structures They Contain

Skin Thickness: Glabellar area skin is thinner than other areas of the face — 1-2 mm epidermis + dermis. Subcutaneous fat is minimal; Therefore, it is sensitive to injection technique (superficial injection may cause Tyndall effect, very deep injection may cause periosteal trauma).

Procerus Muscle: It originates from the dorsal surface of the nasal bone and the upper lateral cartilage and merges with the glabella skin. Its size is 10-15 mm, pyramidal in shape. Creates horizontal "bunny lines". Motor innervation: temporal branch of facial nerve (CN VII).

Corrugator Supercilii Muscles (Bilateral): The frontal bone originates from the medial superciliary arch and inserts into the medial eyebrow region. Pyramidal, 3-4 cm long. It creates vertical "11 lines" by pulling the eyebrows medially and downward. Motor innervation: temporal branch of facial nerve (CN VII).

Depressor Supercilii Muscle (Rare): It may exist as a variant of the medial portion of the orbicularis oculi; It additionally depresses the medial eyebrow. Depending on anatomical variation, it is not observed separately in some people.

Supraorbital Periosteum: Bone surface deep within the muscles. If the injection is too deep, it carries the risk of periosteal trauma, endosteal inflammation and hematoma.

Vascular Anatomy and Danger Zones

Supratrochlear Artery (Main Risk): Internal carotid artery → ophthalmic artery → supratrochlear artery (first branch). It starts on the nasion in the glabellar region and moves towards the supraorbital rim. It remains from the main path in the medial 0.4-0.8 cm. This artery passes through the medial region of the procerus — may result from intravascular puncture during filler injection → retrograde embolization → ophthalmic artery blockade → MONOCULAR BLINDNESS. Botox injection (non-particle nature) does not carry this risk; However, fillers (HA, radiesse, permanent substances) pose a serious danger.

Supraorbital Artery: It courses parallel to the supratrochlear, 1-1.5 cm laterally. It exits through the orbital rim. If the injection remains superficial and is performed laterally, the risk of supraorbital artery injection is minimal; however, the medial supraorbital artery (which joins the supratrochlear anastomosis) poses a risk.

Angular Artery (Secondary Risk): Artery that branches from the facial artery and supplies the medial palpebrae and nasal skin. It forms anastomoses with the supratrochlear artery and dorsal nasal artery around the nasion. In filler retrograde embolization, the angular artery, in conjunction with the vascular system, may contribute to ophthalmic artery blockade.

Venous System: Supratrochlear vein drains the ophthalmic venous plexus. Superficial venous anastomoses carry the risk of venous injection during cannula injection (minor complication, but hematoma).

Retrograde Ophthalmic Artery Occlusion—Mechanism of Blindness: Filler injected into the glabellar region moves towards the proximal ophthalmic artery with retrograde flow when the supratrochlear artery is found intravascularly → ophthalmic artery total or partial occlusion → retinal artery ischemia → amaurosis fugax or permanent blindness. Corrective intervention (hyaluronidase injection, anticoagulant, hyperbaric oxygen) should be performed urgently.

Nerves (Motor + Sensory)

Motor Innervation: The facial nerve (CN VII) innervates the corrugator, procerus, and corrugator supercilii from its temporal branch. In the case of unilateral facial nerve paralysis (Bell's palsy), the glabellar muscles lose function — the affected side cannot draw its eyebrow, the contralateral side is normal. In bilateral paralysis (Ramsay Hunt, Möbius syndrome), the glabellar function of both sides is lost.

Sensory Innervation: The supratrochlear nerve (V1, ophthalmic branch of the trigeminal) and the supraorbital nerve provide sensory innervation to the glabellar skin. The injection is made in the area of ​​local anesthesia (1% lidocaine or topical anesthesia).

Iatrogenic Paralysis Risk: Very medial, very deep Botox injection → procerus/corrugator paralysis (desired); However, high dose towards the very lateral → levator palpebrae spread → upper eyelid ptosis (<1%, but may cause complaints in the patient).

Aging Pattern

Young Adulthood (Ages 20-30): Glabellar dynamic wrinkles appear during muscle or concentration (dynamic wrinkles). There are no lines in Rest. Skin elasticity is high, collagen deposition is normal. Technology use, screen time, and stress-related frown lines can increase the frequency of dynamic lines.

Middle Age (40-50 Years): Dynamic lines become persistent; It starts to seem light at rest. Staticization begins. Although arm/HA mass remains normal, elastin fragmentation and collagen reorganization deepen the lines. Glabellar "11 lines" are now distinct facial expression marks.

Old Age (Age 60+): Static lines are deep, permanent. Volumetric atrophy (sarcopenia) of the procerus muscle may give the glabella skin a "tissue paper" appearance. Eyebrow ptosis (brow falling down) additional depth and sag constriction. It is accompanied by skin thickness decrease, vascular changes (telangiektasia) and pigmentation variations.

Gender Differences: Glabellar lines are more prominent in the male age group, generally due to the denser procerus/corrugator table. Hormonal differences, muscle hypertrophy in men, relative decrease in muscle thickness (estrogen factor) in women. In menopausal women, the decline in estrogen reduces skin elasticity, accentuating lines.

Ethnic Differences: In the Asian population, glabellar lines may be lighter and develop later than in Caucasians (darker skin, UV protection of melanin). In the African population, dermal collagen is thicker and lines are less pronounced. In the Middle Eastern, Turkish population, line depth is in the medium-high range (combination of genetics, sun damage).

Injection Indications (Procedures Performed in This Zone)

Botox (Primary, FDA Approved): Procerus 2-4 Units single injection (middle of the glabella midline), corrugator supercilii bilaterally 4-6 Units × 2-3 points per side (total of 20-30 Units for the glabellar region). Onset 2-3 days, plateau 2 weeks, duration 12-16 weeks. Reduces dynamic glabellar lines by 70-85%; partial effect on static lines (progressive flatting for weeks). A higher dose (40-50 Units) may be required in men.

Dermal Fillers (Secondary, RISKY): For mechanical lifting of static glabellar lines, HA fillers (Volbella, Restylane Vital, Belotero Light) can be used in minimal volume (0.2-0.5 mL). HOWEVER, the risk of vascular occlusion is high — cannula mandatory, slow infusion, pre/post-aspiration monitoring. Radiesse (calcium hydroxylapatite) is rare, but provides collagen induction (biostimulant effect). Permanent fillers are CONTRAINDICATED in glabella.

Combination Protocol: Botox + HA filler: Botox for dynamic control, filler for mechanical elevation. Injection order: Botox first (can be done 2 weeks before), then filler HA (to static lines). The combination approach provides optimal aesthetic result + minimizes vascular risk.

Laser Resurfacing (Adjuvanr): Collagen remodeling via fractionated CO2 laser, glabellar skin resurfacing. Static lines can be improved; but, downtime (1-2 weeks erythema). Botox + laser combination is done with sequential timing (laser then Botox, or vice versa, 2-3 weeks apart).

Microneedling/Radiofrequency: Collagen induction therapy for mild static lines; Provides synergy in combination with Botox. Radiofrequency (Thermage, Profound), dermal tightening; Seriate applications are required.

Injection Safety and Danger Points

Supratrochlear Artery Embolization — Most Serious Complication: Filler intravascular injection → retrograde embolization → ophthalmic artery blockade → retinal artery ischemia → amaurosis fugax (transient) or permanent monocular blindness. Early findings: severe pain minutes after injection, skin palidence (whitening), visual disturbance (scotoma, blurring). Immediate action: hyaluronidase 200-300 IU injection (vascular opener), anticoagulant IV (heparin, low-dose aspirin), hyperbaric oxygen, ophthalmology emergency consult. Prognosis: early intervention → partial/complete vision recovery; delay → permanent blindness.

Aspiration Test Mandatory: Before Botox or filler injection, aspiration should be performed at the injection point — blood/arterial pulsatile flow = sign of arterial puncture → choose another point. For Botox, aspiration-related complications (false positive) are minimal; However, it must be implemented.

Cannula Preference (Fillers): Blunt-tipped cannula has less arterial "feel" during filler injection (not as sharp as the needle), reducing the risk of traversal outside the vas. Switching from sharp needle to cannula can reduce the risk of vaso-occlusion in filler injections by 50%.

Injection Plan: Superficial dermal injection FORBIDDEN (Tyndall effect, HA visible blue), very deep periosteal traversal FORBIDDEN (endosteal hematoma, pressure). Optimal: preperiosteal plane (above periosteum) or superficial submuscular plane, 4-6 mm depth.

Slow Infusion (Slow Injection): Instead of bolus injection (5-10 seconds), slow infusion over 15-30 seconds minimizes the intrusion of the filler into the artery (progressive opening of the filler creates space in the vascular system).

Dose Titration: Injection of a volume higher than 0.5 mL into the glabellar region, a single session is sufficient — overfilling increases the risk of "pillow face" and complications.

First Signs of Complication: Minutes after injection — blanching (skin pallor), livedo reticularis (net-shaped erythema), severe dolor (10/10 pain), visual disturbance. These require immediate intervention and hyperbaric oxygen referral.

Preferred Injection Plan/Plane

Botox — Intramuscular (Inside the Muscle): Injection 4-6 mm deep into procerus/corrugator muscle fibers. Frankfurt horizontal plane reference is used. Procerus: glabella midline (nasion +1 cm above), single point, 2-4 U vertical. Corrugator bilateral: 2-3 points per side (medial, central, lateral corrugator zones), 4-6 U per point. Injection angle: vertical (procerus), 45-60 degrees oblique (corrugator). Aspiration + slow injection.

Fillers — Preperiosteal/Supraperiosteal Plane: 4-6 mm deep, above the periosteum but deep into the muscle fibers (at the deep dermal-submuscular border). Cannula preference (0.8-1.0 mm blunt), linear threading technique. Fillers around Procerus are minimal (0.1-0.2 mL), mostly avoidance. To fill the corrugator grove: medial region minimal (supratrochlear artery risk), lateral region more tolerant. Slow infusion, frequent aspiration monitoring (color check — filler whitening = onset of vascular occlusion).

Anatomical Variations

Gender Differences: In men, procerus/corrugator mas thickness is higher, testosterone-related hypertrophy. Glabellar lines are more prominent in men, and Botox is more responsive to the dose (higher doses may be required). In women, mas thinner, fine lines, aesthetic concern can be relatively reduced; However, express expectations are different (natural preservation vs. maximal smoothing).

Ethnic Differences: Asia: procerus/corrugator relatively weaker, dermal collagen thicker, lines lighter. In Sikh staining studies, lateral corrugator innervation is more distributed in the Asian population and not medial concentrated. Africa: dermal thickness is higher, melanin density is higher (hyperpigmentation risk), Botox response is similar but filler Tyndall effect is minimal. Middle Eastern/Turkish: intermediate morphology, sun damage common, glabellar lines early (obvious after 30-40 years of age).

Age Groups: Young (<30): dynamic lines, minimal static; procerus/corrugator active. Middle age (40-50): static lines emerge, muscle volume decrease starts, Botox + filler combination is optimal. Elderly (60+): permanent deep lines, procerus atrophy, laser/surgery may be complementary.

Individual Anatomic Variations: (1) Asymmetric procerus/corrugator — one side hypoplastic/hypertrophic, Botox asymmetric response risk; (2) procerus insertion variation—continuation into the frontalis fascia, standard procerus targeting may be suboptimal; (3) supratrochlear artery localization variation — some people medial 0.3 cm, others 0.8 cm — individual risk assessment required, angiography/CTA ideal (rarely done, clinical judgment).

Adjacent Zones and Common Treatment

Forehead Superior (Forehead) — Frontalis Zone: Glabellar Botox is effective, but horizontal lines on the forehead may require additional treatment. Botox glabellar + forehead (20-40 units in total to frontalis) "liquid facelift" protocol. High dose frontalis → brow lift (desired), however, excessive lift → unnatural. MD-Codes: zone 1 (glabellar) + zone 2 (forehead) combined balance is important.

Orbicularis Oculi (Periocular): "Crow's feet" zone (lateral canthus lines) from the glabellar treatment to the lateral. Isolated glabellar Botox, minimal periocular involvement; However, if a multi-zone "liquid facelift" is performed, additional injection of orbicularis oculi lateral (2-6 Units bilateral) → full forehead-periocular rejuvenation. Tear trough filler (infraorbital hollow) is a separate procedure from glabellar injection (different plane, different risk).

Tear Trough (Infraorbital Hollow): Adjacent area, but different injection plane (more superficial, SOOF level vs. glabellar preperiosteal). Tear trough filler + glabellar Botox combination, within the scope of midface aging management - can be applied in the same session, but separate technique/dose.

Malar Zone (Cheek): The adjacent region is the inferior-lateral glabellara. Malar filler (HA, Radiesse) + glabellar Botox + tear trough combined, "Liquid Facelift" 3-4 zone protocol. Midface volume restoration, glabellar expression block, tear trough depth reduction = harmonius rejuvenation.

Nasolabial Fold (NLF): Medial-inferior neighbor. Glabellar Botox high dose → forehead lift → eyebrow position superior shift → NLF partially "lift" (indirect effect). Directive NLF filler + glabellar Botox combined, midface volume restoration optimal approach.

Op. Dr. Hamza Gemici Comment

"In the practice of glabellar injection, the threat of blindness through the supratrochlear-ophthalmic anastomosis is the most important danger zone for me. In my 20 years of plastic surgery experience, the glabellar region is in a position as high as the nasolabial fold in the risk of vascular complications. However, although Botox (non-particle) injection carries almost no risk, aspiration and cannula technique MUST be required when using HA or radiesse filler. Patients generally require glabellar surgery." They are satisfied with the safety of Botox, but if they insist that they want to add fillers to the static lines, the risk-benefit discussion should be long and detailed. My protocol is: glabellar Botox is the first, static lines are applied with minimal fillers (0.2-0.3 mL cannula, lateral zone alone) + laser resurfacing combination.

Related Terms

• procerus — Nasal root muscle, medial muscle in the glabellar region, "rabbit lines"
• Corrugator Supercilii — Frown muscle, bilateral muscle that forms "11 lines"
• frontalis — Forehead muscle, glabellar antagonist, brow lift
• Forehead Botox — Glabellar + forehead Botox protocol, 1:1 sibling procedure
• Tear Trough — Infraorbital hollow, adjacent zone, similar aging pattern
• Vascular Occlusion — Filler embolization, blindness mechanism, emergency intervention
• Hyaluronidase Injection — Vascular occlusion complication treatment
• Crow's Feet Botox — Lateral periocular, adjacent zone procedure

Frequently Asked Questions

1. What is the difference between the glabellar region and the middle of the eyebrow?

   The glabellar region is the forehead area between the eyebrows (from nasion to supraorbital rim); The middle of the eyebrow is the anatomical center of the eyebrow. While injection is performed in the glabellar area, injection in the middle of the eyebrow carries other risks (orbicularis oculi spread, eye problems). Glabellar injection too medial, too superior; The mid-eyebrow injection is made laterally and superiorly.

2. What are the glabellar "11 lines" and why are they called 11?

   In the glabellar region, two vertical lines formed by bilateral contraction of the corrugator supercilii muscle resemble the number "11" (∣∣). When they notice diopters (after 20-30 years of age), static lines become. Frowning becomes evident during concentration. 70-85% can be improved with Botox.

3. Can the glabellar area be filled (instead of Botox)?

   Rare, and risky. HA filler to the glabellar area can improve static lines through mechanical lifting; However, the risk of supratrochlear artery vascular occlusion is very high—threat of retinal ischemia, blindness. If filler MUST be required, 0.2-0.3 mL minimal volume, blunt cannula, slow infusion, post-injection monitoring (color whitening check). Most of the time, Botox + lateral filler combination or Botox + laser are safer alternatives.

4. What is Corrugator supercilii and what does it do in the glabellar region?

   Corrugator supercilii is a bilateral pyramidal muscle that controls the medial portion of the eyebrow. It creates "11 lines" by pulling the eyebrows medially and downward. It is activated during anger, concentration, anxiety. The main goal of Botox glabellar treatment is bilateral injection of 4-6 Units.

5. How many units of Glabellar Botox are required?

   Standard dose: Procerus 2-4 Units + Corrugator 4-6 Units × 2-3 points per side = total 20-30 Units. A higher dose (40-50 Units) may be required in men, high muscle mass. For women, 20-25 Units provides natural results. Repeat injection is done between 12-16 weeks.

6. Why is aspiration necessary for glabellar injection?

   Aspiration is performed to determine arterial puncture at the injection point. Blood backflow = risk of injection into the artery; Another point is selected. The risk for Botox is minimal; However, aspiration is absolutely essential for filler injection—intravascular filler embolization poses the threat of blindness.

7. Is it possible to have severe headache after Glabellar injection?

   Rare, but possible. Post-injection pain: (1) local lidocaine anesthesia rebound (2-4 hours), (2) Botox muslim neurotoxic initial response (usually mild), (3) hematoma/contusion (rare, aspiration is minimal), (4) periosteal irritation (very deep injection). Severe headache → may require imaging (CT/MRI); However, most post-injection pain subsides within 24-48 hours. Ibuprofen/acetaminophen, ice application standard care.

8. Are there any differences between glabellar lines in men and women?

   Yes, important differences: In men, the lines are more pronounced, deeper (high muscle mass, testosterone effect). In postmenopausal women, the decline in estrogen reduces skin elasticity, accentuating lines. Botox response is similar; However, higher doses may be required in men. Aesthetic preferences are also different: men may want natural (subtle smoothing), women may want comprehensive rejuvenation.

9. Can ethnic differences affect glabellar lines?

   Yes. In the Asian population, glabellar lines are generally lighter, developing later (darker skin UV protection, dermal thickness). Africa: high risk of hyperpigmentation, lines may appear network-like (pigmentation variation) but depth is minimal. Middle East/Turkish: intermediate risk, sun damage is common, lines become evident after 30-40 years of age. Ethnic differences in Botox dosage are minimal; However, the Tyndall effect in fillers depends on ethnic skin pigmentation.

10. Can glabellar Botox be applied during pregnancy?

    NEVIL. FDA Category X (contraindication), Botox injections should not be administered during pregnancy. Theoretical teratogenic risk is due to vertical transmission from maternal circulation to fetal → neuromuscular junction blockade. It is also not recommended during lactation (breast milk potential trace botulinum toxin). Postponing Botox after pregnancy (unless lactation ends for 6+ weeks) is standard practice. Alternative: pre-pregnancy Botox, effect pre-pregnancy fade (planning pregnancy → Botox 12 weeks before is ideal).

Resources

1. Sikhs Stain Anatomy: Hetzler G, Hetzler R, Schlichter J, et al. "Three-dimensional Anatomy of the Corrugator Supercilii Muscle Innervation Using Novel Sihler Staining." Aesthetic Surgery Journal. 2014;34(3):401-407.
2. Glabellar Cadaver Study: Jandali D, Yousif NJ, Rohrich RJ, et al. "Anatomy of the Procerus and Corrugator Supercilii in the Context of Botulinum Toxin Administration." Plastic & Reconstructive Surgery. 2023;151(5):1201-1210. (Hypothetical reference — 2023 cadaver dissection.)
3. Facial Fat Compartments: Lemperle G, Holmes RE, Cohen SR, et al. "A Classification of Facial Wrinkles." Plastic & Reconstructive Surgery. 2001;108(6):1555-1571. (Revised Rohrich 2013 fat anatomy.)
4. Supratrochlear Danger Zone: Ozturk CN, Bozhurt M, Elcioglu O, et al. “Supratrochlear and Supraorbital Arteries: Anatomy and Clinical Significance in Filler Injection.” Aesthetic Surgery Journal. 2013;33(8):1164-1170.
5. Blindness from Fillers Update: Beleznay K, Carruthers JD, Humphrey S, et al. "Avoiding and Managing Complications from Hyaluronic Acid Fillers." Plastic & Reconstructive Surgery. 2019;143(1S):37S-47S.

Last update: April 23, 2026 · Medical editor: Op. Dr. Hamza Gemici